Comparison between predicted death rates by APACHE II and MPMo scores in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 83s Year: 2002
Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)? Source: Eur Respir J 2001; 18: Suppl. 33, 241s Year: 2001
Application of an outcome prediction model for hospitalized patients with exacerbation of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 55s Year: 2005
The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011
Impact of exacerbation on health status deterioration in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 24s Year: 2001
An evaluation of the validity of two measurements of dyspnoea as outcomes of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 182s Year: 2002
Proactive integrated care improves quality of life in patients with COPD Source: Eur Respir J 2009; 33: 1031-1038 Year: 2009
Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation Source: Eur Respir J 2008; 31: 563-570 Year: 2008
Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016
Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD exacerbation Year: 2012
Severity assessment in acute exacerbations of COPD Source: Annual Congress 2005 - Infection and acute exacerbation of COPD: what do we know? Year: 2005
Acute exacerbations of chronic obstructive pulmonary disease, clinical characteristics and predictors of exacerbations rate Source: Eur Respir J 2006; 28: Suppl. 50, 625s Year: 2006
The comparisons of severity scoring systems for community acquired pneumonia patients with chronic obstructive pulmonary disease Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017
Does the chronic respiratory disease questionnaire (CRDQ) relate to hospital admission rates in chronic obstructive pulmonary disease (COPD) patients Source: Eur Respir J 2002; 20: Suppl. 38, 249s Year: 2002
Impact of co-morbidities on the rehabilitation outcome in COPD patients Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation Year: 2007
Comparison of the different dyspnoea scales in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 240s Year: 2003
Prediction of exacerbation in one-year follow-up of patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020
Subjective symptoms and functional performances in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - Nursing challenges at home and in hospital Year: 2009
The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016
Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013